LCTX vs XPEV · rev $2.8M vs rev $895.7M
Lineage Cell Therapeutics Inc (LCTX) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
LCTX currently screens at market cap $213.6M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the LCTX and XPEV stock pages for the full models.
Not investment advice.